http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201991473-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201991473-A1
titleOfInvention IMIDAZOPYRROLOPYRIDINE AS AN INHIBITOR KINASE KINASE FAMILY JAK
abstract Compounds 2 - ((1r, 4r) -4- (imidazo [4,5-d] pyrrolo [2,3-b] pyridin-1 (6H) -yl) cyclohexyl) acetonitrile, pharmaceutical compositions containing them, methods for their preparation and methods for their use, including methods for treating JAK-mediated diseases, disorders and conditions, such as inflammatory bowel disease.
priorityDate 2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502

Total number of triples: 16.